BVS

Bioventus Stock Analysis

AI Rating

Good
  • Quality4/10
  • Growth 8/10
  • Value 7/10
Bioventus sales and earnings growth
BVS Growth
Good
  • Revenue Y/Y -0.91%
  • EPS Y/Y 160.71%
  • FCF Y/Y 90.83%
Bioventus gross and profit margin trends
BVS Profitability
Fair
  • Gross margin 68.30%
  • EPS margin 4.00%
  • ROIC 5Y -10.24%
Bioventus net debt vs free cash flow
BVS Risk
Good
  • Debt / Equity 1.3
  • Debt / FCF 3.4
  • Interest coverage 1.8

Bioventus stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Medical Devices stocks ↗